Locations:
Search IconSearch

Tag: melanoma

Seth Rotz, MD, exams patient's throat during clinical exam

Study Reveals New Clues Into Childhood Cancer Survivors’ Increased Risk of Melanoma

Largest study of its kind identifies three treatment exposures that contribute to risk

Eye with a lesion on the iris

Iris Freckle, Mole or Melanoma? How to Tell the Difference

A new online calculator can determine probability of melanoma

Novel Therapeutics Clinic
February 10, 2023/Cancer/Research

Novel Therapeutics Clinic Offers Access to Early-Phase Trials for Solid Tumors

Dedicated investigators and clinicians bring expertise in drug development and flexible study design

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

melanoma
November 2, 2022/Cancer/Research

Questions Remain about When to Employ Immunotherapy for Resected High-Risk Melanoma

Timing of adjuvant immunotherapy unclear for maximum overall survival

gettyimages-958769278-170667a-1
May 6, 2022/Cancer/Innovations

The Changing Treatment Landscape for Patients with Metastatic Melanoma

Immune therapy and targeted therapies have led to durable responses and potential cures

3d illustration of a cross-section of a diseased skin with melanoma that enters the bloodstream and lymphatic tract
February 24, 2022/Cancer/Surgical Oncology

New Model Based on CD8 T Cells May Distinguish ICI Responders from Non-Responders in Melanoma

Study finds high levels of a CD8 T-cell subpopulation to be predictive of ICI resistance

Chimeric antigen receptor on T-cell, illustration
June 11, 2021/Cancer/Innovations

Cellular Therapy Across Cleveland Clinic

A brief look at our programs

20-EYE-1989584-CQD-Case-study-melanoma-Iris-Hero
November 24, 2020/Cancer

Small-Incision Guarded Hydroaspiration in Patient with Small Iris Lesion

35-year-old presents with suspected iris melanoma

BackPage 1 of 3Next

Advertisement

Ad